Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krakauer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neurology|May 5, 2010
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic responseD Hesse, M Krakauer, H Lund, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2011
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosisF Sellebjerg, C J Hedegaard, M Krakauer, et al.
European Journal of Neurology|June 30, 2009
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluationF Sellebjerg, M Krakauer, D Hesse, et al.
Diabetology & Metabolic Syndrome|January 4, 2021
Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position StatementM Rodacki, L E Calliari, A C Ramalho, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurology|May 5, 2010
Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic responseD Hesse, M Krakauer, H Lund, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2011
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosisF Sellebjerg, C J Hedegaard, M Krakauer, et al.
European Journal of Neurology|June 30, 2009
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluationF Sellebjerg, M Krakauer, D Hesse, et al.
Diabetology & Metabolic Syndrome|January 4, 2021
Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position StatementM Rodacki, L E Calliari, A C Ramalho, et al.
Pageof 2